BATON ROUGE, Louisiana (April 5, 2010) - Amedisys, Inc. (NASDAQ: "AMED") one of America's leading home care and hospice companies, announced today that James (Jim) T. Robinson, most recently of American CareSource Holdings, Inc., has joined Amedisys as the Company’s new Executive Vice President of Hospice.

“Jim brings a unique combination of skills and healthcare experience to Amedisys and is going to be an excellent addition to our senior executive team,” stated William F. Borne, Amedisys Chief Executive Officer. "His track record in growing hospice programs combined with his breadth of knowledge in building and growing healthcare companies strengthens our hospice management team. We’re counting on Jim to provide the leadership, knowledge and creativity required to help Amedisys become the leading provider of comprehensive in-home end-of-life care and hospice services in the country.”

Over the past 20 years, Mr. Robinson has been on the leading edge of healthcare innovation and has either led or has been a member of the senior management team of five healthcare companies spanning cardiovascular medical devices; e-health; physician-to-patient communication; pharmaceutical CRM services; end of life and hospice care; alternative care delivery sites; and payor cost containment services. In his role as Executive Vice President of Amedisys’ Hospice business unit, Mr. Robinson will be responsible for the growth and overall performance of the company’s hospice organization.

“I’m very excited about joining Amedisys at this time,” said Mr. Robinson. “Amedisys is uniquely positioned to provide a full continuum of cost-effective, compassionate, comprehensive health care from the time a patient becomes a high utilizer of healthcare services to the end-of-life. And by linking our growing hospice programs to Amedisys’ home health agencies in communities all across the country, we should be able to grow our hospice census significantly over the next several years and provide streamlined, seamless care at home to our patients and their families.”

From 2006 to 2008, Mr. Robinson served as Executive Vice President and Chief Marketing Officer of VistaCare, Inc., where he helped lead the turnaround and eventual sale of the $230 million nationwide hospice/healthcare services company to Odyssey HealthCare.

Prior to joining VistaCare, Mr. Robinson was President & CEO of HealthBanks, Inc., an innovative, private-equity backed e-Health Network Company that connects specialty physicians to their patients. Before HealthBanks, he was co-founder of Avicenna Systems Corporation, a venture capital backed e-health physician practice solutions company that was acquired by WebMD. Mr. Robinson has also held a variety of management positions with St. Jude Medical, Inc., Hewlett Packard Medical Systems, and the Xerox Corporation. He earned a Bachelor of Arts from Connecticut College and holds an MBA from Harvard University. Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol “AMED.”

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe”, “estimate”, “project”, “expect”, “anticipate” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Many of the factors that could cause or contribute to such differences are described in the Company’s periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management’s control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).